Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Safe care for people with diabetes in hospital

Ketan Dhatariya, Omar G Mustafa and Gerry Rayman
Download PDF
DOI: https://doi.org/10.7861/clinmed.2019-0255
Clin Med January 2020
Ketan Dhatariya
AElsie Bertram Diabetes Centre, Norwich, UK and Norwich Medical School, Norwich, UK
Roles: consultant in diabetes and endocrinology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ketan.dhatariya@nnuh.nhs.uk
Omar G Mustafa
BKing's College Hospital NHS Foundation Trust, London, UK
Roles: consultant in diabetes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerry Rayman
CNorwich Medical School, Norwich, UK and Ipswich Hospital, Ipswich, UK
Roles: consultant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

ABSTRACT

Diabetes is the most prevalent long-term condition, occurring in approximately 6.5% of the UK population. However, an average of 18% of all acute hospital beds are occupied by someone with diabetes. Having diabetes in hospital is associated with increased harm – however that may be defined. Over the last few years the groups such as the Joint British Diabetes Societies for Inpatient Care have produced guidelines to help medical and nursing staff manage inpatients with diabetes. These guidelines have been rapidly adopted across the UK. The National Diabetes Inpatient Audit has shown that over the last few years the care for people with diabetes has slowly improved, but there remain challenges in terms of providing appropriate staffing and education. Patient safety is paramount, and thus there remains a lot to do to ensure this vulnerable group of people are not at increased risk of harm.

KEYWORDS
  • Inpatient
  • optimisation
  • diabetes
  • dysglycaemia
  • harm

Introduction

The current estimate for the prevalence of diabetes in the UK is approximately 6.5% and yet the National Diabetes Inpatient Audit (NaDIA), which is an almost annual event over the last several years, has shown the prevalence of patients with diabetes occupying an acute hospital bed has steadily risen to an average 18%.1,2 The vast majority of these individuals are not in hospital because of their diabetes, but they have diabetes in addition to whatever other condition they were admitted with.

Recent data have suggested that one in 20 people being treated in a medical care setting experiences harm.3 There are now several data to show that having diabetes in hospital also increases the risk of harm, however that harm is defined.4 Most commonly this is an increased risk of hypoglycaemia – mild (ie self-treated) or severe (ie requiring third-party assistance), or hyperglycaemia (including the occurrence of diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemia state), medication errors, hospital acquired foot ulcers and overall increase in death.5–7 When these harms occur, it is often associated with an increased length of stay (Table 1 and Box 1).7 As recently described, there are a number of quality improvement initiatives that can improve the safe delivery of care for inpatients with complex needs.8 A few of the risk mitigation strategies that have become available in commonly encountered scenarios in hospital are discussed. The data that are available can be used by specialist teams to ensure that they have sufficient resources to provide safe and appropriate care for the increasing number of people with diabetes occupying an acute hospital bed. Non-specialists can use these data to ensure that they are aware of the issues facing these vulnerable individuals and that, in addition to safety, the suboptimal care that people with diabetes often receive leads to increasing length of stay and thus higher costs to the health economy.6,9

View this table:
  • View inline
  • View popup
Table 1.

Examples of harm. Data from Joint British Diabetes Societies for Inpatient Care. A good inpatient diabetes service. JBDS-IP, 2019.7

View this table:
  • View inline
  • View popup
Box 1.

Examples of insulin errors. Adapted from Joint British Diabetes Societies for Inpatient Care. A good inpatient diabetes service. JBDS-IP, 2019.7

The patient perspective

Most individuals with diabetes who answered the 2017 NaDIA patient bedside questionnaire reported being either satisfied or very satisfied with the diabetes care they had experienced during their hospital stay.2 However, there were a number of other important parts of their management that they were not satisfied with in particular with the choice of food that is offered and the timing of the meal in relation to their diabetes medications.10 The addition of the carbohydrate content of meals to the menu would allow those who carbohydrate count to dose themselves with greater accuracy than at present. The routine provision of bedtime snacks would also help to reduce the frequency of night time hypoglycaemia.11

Diabetes UK also carried out a survey of people with diabetes while they were in hospital and more than half of the individuals said that they did not feel they were in control of their diabetes and an almost equal number felt that they did not trust the healthcare professionals who cared for them while they were in hospital.12 Almost half of the individuals who replied to the survey reported an ongoing concern about their diabetes care if they ever had to be in hospital again. The lack of control led to them having feelings of anxiety and fear, as well as frustration and the increased stress of having to advocate for themselves during this difficult time. Thus, to try and improve care, hospitals should put into place increased diabetes training for medical and nursing staff to allow them to manage diabetes better, to understand the needs and concerns of the people with diabetes and to support them to self-manage when appropriate. Essential to this is an inpatient diabetes specialist team to support the upskilling of the medical and nursing staff who look after these individuals and to be readily accessible to those people with diabetes who require specialist input.

The National Diabetes Inpatient Audit

NaDIA is the world's first national audit of bedside inpatient diabetes care. The data show that between 2011 and 2018, the prevalence of inpatient diabetes in England and Wales rose from 14.9% to 17.9%. In some hospitals the prevalence of people with diabetes occupying a hospital bed is as high as 30%.2

In addition, approximately one in 25 people with type 1 diabetes admitted to hospital experience an episode of DKA during that admission.2 A smaller proportion experience an episode of hyperosmolar hyperglycaemic state (HHS). One in five people experience an episode of low blood glucose concentrations and of most concern, possibly, is that one in three experience a medication error. Insulin is one of the most high-risk medications, and errors arise due to several factors including unfamiliarity (and similarity) of insulin names and action profiles, and the use of the abbreviation ‘u’, instead of ‘units’ on hand written charts. In addition, the multiple new diabetes medications may be a mystery to those not familiar with them.

While there are data to show that dysglycaemia (high or low blood glucose concentrations) is associated with harm,13 until very recently there has been little evidence to show that improving diabetes care made a difference to outcomes.14 However, there are now emerging data from the surgical field and on intensive care to show that maintaining good glycaemic control is associated with a reduction in the level of harm.15 However, pathways to optimise glycaemic control – particularly within the surgical population – have been hard to implement.16

This increased length of stay and increased harm that occurs to people with diabetes in hospital, is associated with significant cost implications. Part of this is the lack of specialist staff. For example, the most recent NaDIA data show that almost one in seven hospitals in England and Wales have no inpatient podiatry service, despite diabetes related foot problems being the commonest reason for a ‘diabetes specific’ hospital admission, and the costs of hospital admission for foot disease being estimated at £322 million.17 People with diabetes are also at greater risk of developing hospital acquired foot lesions, with a relative risk of 2.24 compared to those without diabetes.18 The good news, however, is that NaDIA suggests there has been a significant reduction in hospital acquired foot ulcerations, dropping from 2.2% in 2010 to 0.97% in 2017.2

There are other areas that could be addressed to improve the care of people with diabetes in hospital. Almost two-thirds of all hospitals have no specialist inpatient dietetics service for people with diabetes, meaning the opportunity to explain the intimate relationship between diet and diabetes to patients and staff is lost. And less than one in 11 provide a 7-day specialist diabetes inpatient specialist nurse service. People with diabetes also felt that there was a lack of knowledge among the staff caring for them while in hospital. This is consistent from a junior doctor's point of view as well, with data showing that diabetes care is one of the main areas where knowledge among front-line medical staff is low.19

One of the ways in which harm can be reduced is by increasing the education and training of healthcare professionals involving the care of people with diabetes in hospital.10 Nursing staff also benefit from inpatient diabetes education.20 This raises the question of whether all healthcare professionals in hospitals and other care institutions should have regular mandatory training for diabetes.

Hypoglycaemia

Hypoglycaemia is an extremely common reason why people are taken to the emergency room and the occurrence of hypoglycaemia during hospital admission is associated with an increased length of stay and increase in hospital mortality.21 There are many reasons why people in hospital could experience hypoglycaemia (Table 2).22 Therefore, avoidance of hypoglycaemia is an important consideration. It has recently been shown that the use of a colour coded glucose chart is associated with the prevention of hypoglycaemia and reduction in length of stay.23 In addition, the increasing use of electronic prescribing may be one of the factors that has led to a reduction in prescribing errors seen in NaDIA.2 The use of electronic medical records and integrated network blood glucose testing also make a similar impact but this has not yet been determined.

View this table:
  • View inline
  • View popup
Table 2.

Risk factors for developing hypoglycaemia in hospital. Adapted from Walden E, Stanisstreet D, Graveling A et al. The hospital management of hypoglycaemia in adults with diabetes mellitus, 3rd edn. Joint British Diabetes Societies for Inpatient Care, 2018.22

Diabetes at the front door

The increasing prevalence of diabetes in the community and the occurrence of stress hyperglycaemia (ie hyperglycaemia that occurs during times of physiological trespass that often resolves once the underlying problem has resolved) remains a challenge. In response to this, the Joint British Diabetes Society for Inpatient Care (JBDS-IP) has recently produced a guideline which suggests that any person who is unwell, who presents to an emergency department, regardless of whether they are known to have diabetes or not, should have a random capillary glucose measured.24 If the glucose is less than 11.0 mmol/L and they have no additional risk factors for the development of hyperglycaemia, then no further action needs to be taken. However, if an initial capillary glucose is greater than 11.0 mmol/L at presentation and they have any risk factors for the development of hyperglycaemia then they should have a venous gas taken to exclude DKA, and their feet should be examined for signs of ischaemia, infection or injury. These risk factors are listed in Box 2. It should be remembered that hyperglycaemia most frequently occurs due to a mismatch between glucose concentrations, carbohydrate intake and insulin dose. However, if DKA is excluded and the feet are fine, then capillary concentrations should be measured every 4–6 hours during the first 24 hours. If at any time the glucose is greater than 30.0 mmol/L then a serum osmolality should be calculated to exclude HHS.25

View this table:
  • View inline
  • View popup
Box 2.

Risk factors for developing hyperglycaemia

Individuals known to have diabetes should have a random capillary glucose measured, and those at risk – eg those who present with a glucose >11.1 mmol/L, those with a history of DKA or those on sodium-glucose cotransporter-2 (SGLT2) inhibitors should have a ketone concentration measured because DKA can occur with a normal blood glucose concentration.26

Perioperative diabetes care

Perioperative diabetes care consists of the journey starting at primary care, through to referral to surgical outpatients, then on to the preoperative assessment clinic, through to admission, theatres and recovery, and then through to discharge.27 At each stage of this journey the primary goal is communicating that the individual has diabetes, what kind of diabetes they have and how they are treated. There is guidance on this which is now firmly embedded in UK anaesthetic practice.28 This is timely, because there are data to show that people with diabetes are less likely to be offered day-case surgery, once again increasing the length of stay for people with diabetes and increasing costs.9 A recent document from the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) looked at the entire care pathway for people with diabetes undergoing surgery and came up with several recommendations which would improve the perioperative care of people with diabetes.29 The road to improving care starts with good communication, but there are also data to show that even though just under 9% of all referrals made to all surgical specialties were for people with diabetes, a substantial proportion of those referral letters had no mention of diabetes in the referral letter.30 The JBDS-IP has produced a specific guideline on the management of perioperative care, which has been taken up very extensively around the UK and other parts of the world, suggesting that for elective surgery, glycated haemoglobin (HbA1c) should be less than 69 mmol/mol before any procedure is undertaken because of the risks of harm.27

Hyperglycaemia and acute coronary syndrome

To date, there is no consensus on how hyperglycaemia in the context of acute coronary syndrome should be managed, with a variety of different recommendations from international organisations (Table 3).31–36

View this table:
  • View inline
  • View popup
Table 3.

Summary of guidelines for the management of patients with acute coronary syndrome and diabetes

Hyperglycaemia and glucocorticoid use

The management in steroids in people who are either known to have diabetes or not known to have diabetes is complex. Steroid administration in hospital is common and it is well recognised that high-dose steroids can worsen existing diabetes or can induce diabetes in those people who are at risk.37,38 A recent systematic review suggested that there are little data to show which is the best management strategy for this condition, thus for individuals with variable intake, an insulin-based regimen may be the most appropriate strategy while in hospital.39

Diabetes in the delivery suite

The management of diabetes in the delivery unit is an area that has received little attention to date. It is estimated that about 5% of all women who become pregnant in the UK have either pre-existing diabetes or develop gestational diabetes during their pregnancy. Recent data has highlighted the lack of knowledge among midwifes and a need for further education.40 While the management of diabetes in pregnancy is outside the scope of this paper, the management of diabetes at the time of delivery is an important aspect to consider, in particular, because many woman with diabetes are given steroids when there is a risk of the baby being delivered early. This can worsen glycaemic control, and it is essential to keep glucose concentrations within an agreed reference range to reduce the risk of neonatal hypoglycaemia.41,42 Because of the prolonged fasting that women often go through when in labour, there is a rationale to use a variable rate intravenous insulin infusion, however, if used, meticulous attention must be given to the adjustment of the infusion rate in response to no less than hourly blood glucose monitoring to avoid hypoglycaemia. Hypoglycaemia could be avoided by setting a higher lower limit of blood glucose but, as yet, there is no consensus on how low blood glucose concentrations should be maintained to minimise the risk of neonatal hypoglycaemia.43–45

Diabetes on the renal unit

Estimating the overall glycaemic control in people who are undergoing dialysis is difficult because HbA1c is not a useful measurement in this condition due to overestimation from carbamylation of haemoglobin. This can make it difficult to establish good diabetes control in these patients. In addition, rapid fluid changes and the presence of several comorbidities makes the care of people with diabetes on the dialysis unit very challenging.46 In particular, they often have peripheral vascular disease and are at great risk of developing diabetes-related foot disease.47 Individuals with chronic kidney disease or on dialysis also have a higher risk of hypoglycaemia and avoidance of hypoglycaemia should remain a priority particularly when they are acutely unwell.

Protocol driven management of dysglycaemia

Given the multiple complexities of managing inpatients with diabetes, there are data showing that when protocols are followed, outcomes are improved.48,49 In the UK, an inquiry into excess deaths at one hospital suggested that one of the causes was an excess in variation in care and therefore any attempt to reduce variations in care across institutions and within institutions is to be welcomed.50 It is perhaps for this reason that within the UK the JBDS-IP guidelines have been rapidly adopted because, even though they are consensus based, they are recognised as being useful, practical and of good quality.4

Technology and innovation in diabetes

There are, of course, many innovations in the pipeline that may further improve safety, including the use of technology. The use of network glucose monitoring allows diabetes inpatient teams to focus on those individuals who have severe or recurrent hypoglycaemia or hyperglycaemia, thus enabling teams to target limited resources appropriately. The increasing use of electronic prescribing may be one of the factors that has led to a reduction in prescribing errors seen in NaDIA.2 In addition, the JBDS-IP has for the last few years run an inpatient insulin safety award, named after the former national clinical director for diabetes in England and Wales, Dr Rowan Hillson. These awards have been won by the most useful initiatives using the wider multidisciplinary team, eg the best insulin prescription chart, and the best pharmacy and diabetes team initiative to improve insulin prescribing safety.51,52 Other categories have been the best digital initiative and the best hypoglycaemia avoidance initiative.53,54

The use of closed looped systems in inpatients is a technology currently under development and has shown some promising results.55,56 There are also data to show that education in insulin prescribing reduces insulin errors.57 Whether electronic records and electronic prescribing will make a difference to the incidence and prevalence of prescribing errors remains to be seen.

Increasingly, people with diabetes use technology including insulin pumps, continuous glucose monitoring and flash monitoring systems.58 For the vast majority of people using these technologies, the specialist diabetes team will have provided them with the skills and knowledge on how to use these devices appropriately. However, when admitted to hospital, many staff are unfamiliar with the devices and thus there is a need for them to be aware of these technologies to avoid harm (eg DKA or hypoglycaemia) and potential damage as a result of inappropriate discontinuation in those undergoing surgery or investigations (eg magnetic resonance imaging). Thus, the ability to ‘know what you don't know’ and then close liaison with the specialist diabetes team is essential.

Summary and conclusion

There have been some significant strides in improving the care for hospital inpatients with diabetes over the last few years. However, there remains a large amount to do and the data suggest that patient safety is still being compromised. To reduce these risks, the ongoing education of medical and nursing staff, and all other groups involved in the care of patients with diabetes in hospital remains paramount given the increasing prevalence of the condition and its ongoing impact. As part of this, the Care Quality Commission working with the JBDS-IP is looking at the management of inpatients with diabetes as a marker of quality of care across all aspects of inpatient management. However, ultimately the provision of safe and effective care of the person with diabetes in hospital will rely on the recognition by senior management that, by investing in diabetes inpatient services, there may be a lot to be gained. For non-specialists looking after people with diabetes, there are a number of resources available which, together with communication with the local diabetes teams, should help teams improve the provision of safe and effective care.24

  • © Royal College of Physicians 2020. All rights reserved.

References

  1. ↵
    1. International Diabetes Federation
    . IDF diabetes altas, 9th edn. Brussels: IDF, 2019. www.diabetesatlas.org [Accessed 21 November 2019].
  2. ↵
    1. NHS
    . National Diabetes Inpatient Audit (NaDIA) - 2017. NHS Digital, 2018. https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-inpatient-audit/national-diabetes-inpatient-audit-nadia-2017 [Accessed 08 October 2019].
  3. ↵
    1. Panagioti M
    , Khan K, Keers RN, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ 2019;366:l4185.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Sampson M
    , Jones C. Joint British Diabetes Societies for Inpatient Care: clinical guidelines and improving inpatient diabetes care. Diabetic Med 2018;35:988–91.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Nirantharakumar K
    , Hemming K, Narendran P, et al. A prediction model for adverse outcome in hospitalized patients with diabetes. Diabetes Care 2013;36:3566–72.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Sampson MJ
    , Dozio N, Ferguson B, Dhatariya K. Total and excess bed occupancy by age, speciality and insulin use for nearly one million diabetes patients discharged from all English Acute Hospitals. Diabetes Res Clin Pract 2007;77:92–8.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Joint British Diabetes Societies for Inpatient Care.
    A good inpatient diabetes service. JBDS-IP, 2019. https://abcd.care/sites/abcd.care/files/resources/A_good_Inpatient%20Service_FINAL_Aug_19.pdf [Accessed 08 October 2019].
  8. ↵
    1. Dean J
    , Vaux E. Update from RCP Quality Improvement: QI, what do we need to learn? FHJ 2019;6:91–2.
    OpenUrl
  9. ↵
    1. Kerr M
    . Inpatient care for people with diabetes: The economic case for change. NHS, 2011. http://webarchive.nationalarchives.gov.uk/20130513172211/http://www.diabetes.nhs.uk/document.php?o=3034 [Accessed 08 October 2019].
  10. ↵
    1. Rutter CL
    , Jones C, Dhatariya KK, et al. Determining in-patient diabetes treatment satisfaction in the UK—the DIPSat study. Diabetic Med 2013;30:731–8.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Rajendran R
    , Kerry C, Rayman G, on behalf of the MaGIC study group. Temporal patterns of hypoglycaemia and burden of sulfonylurea-related hypoglycaemia in UK hospitals: a retrospective multicentre audit of hospitalised patients with diabetes. BMJ Open 2014;4:e005165.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Diabetes UK
    . Diabetes inpatient and hospital care. Diabetes UK, 2018. www.diabetes.org.uk/professionals/resources/shared-practice/inpatient-and-hospital-care [Accessed 08 October 2019].
  13. ↵
    1. Timmons JG
    , Cunningham SG, Sainsbury CA, Jones GC. Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes. J Diabetes Complications 2017;31:479–82.
    OpenUrl
  14. ↵
    1. Dhatariya K
    . Should inpatient hyperglycaemia be treated? Br Med J 2013;346:f134.
    OpenUrlFREE Full Text
  15. ↵
    1. Wang YY
    , Hu SF, Ying HM, et al. Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: A meta-analysis. BMC Endocr Disord 2018;18:42.
    OpenUrl
  16. ↵
    1. Hommel I
    , Wollersheim H, Tack CJ, et al. Impact of a multifaceted strategy to improve perioperative diabetes care. Diabetic Med 2017;34:278–85.
    OpenUrl
  17. ↵
    1. Kerr M
    , Barron E, Chadwick P, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabetic Med 2019;36:995–1002.
    OpenUrl
  18. ↵
    1. Wensley F
    , Kerry C, Rayman G. Increased risk of hospital-acquired foot ulcers in people with diabetes: large prospective study and implications for practice. BMJ Open Diab Res Care 2018;6:e000510.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. George JT
    , Warriner D, McGrane DJ, et al. Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) diabetes study. QJM 2011;104:761–6.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Holmes C
    , Dyer P. Diabetes training for nurses: The effectiveness of an inpatient diabetes half-day workshop. J Diab Nurs 2013;17:86–94.
    OpenUrl
  21. ↵
    1. Nirantharakumar K
    , Marshall T, Kennedy A, et al. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized. Diabetic Med 2012;29:e445–8.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Walden E
    , Stanisstreet D, Graveling A, et al. The hospital management of hypoglycaemia in adults with diabetes mellitus, 3rd edn. Joint British Diabetes Societies for Inpatient Care, 2018. www.diabetologists-abcd.org.uk/JBDS/JBDS_HypoGuideline_Revised_v2_08052018.pdf [Accessed 08 October 2019].
  23. ↵
    1. Sharma D
    , Gerlach M, Sharma V, Dhatariya K. Does the use of a colour coded inpatient capillary blood glucose monitoring chart influence outcomes? Br J Diab 2019;19:19–24.
    OpenUrl
  24. ↵
    1. Joint British Diabetes Societies Inpatient Care Group
    . Guidelines. JBDS-IP, 2019. https://abcd.care/joint-british-diabetes-societies-jbds-inpatient-care-group [Accessed 08 October 2019].
  25. ↵
    1. Scott A
    , Joint British Diabetes Societies (JBDS) for Inpatient Care, JBDS hyperosmolar hyperglycaemic guidelines group. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabetic Med 2015;32:714–24.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Macfarlane J
    , Dhatariya K. The incidence of euglycemic diabetic ketoacidosis in adults with type 1 diabetes in the UK prior to the widespread use of sodium glucose co-transporter 2 inhibitors. Mayo Clin Proc 2019;94:1909–10.
    OpenUrl
  27. ↵
    1. Dhatariya K
    , Levy N, Kilvert A, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabetic Med 2012;29:420–33.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Royal College of Anaesthetists
    . Guidelines for the Provision of Anaesthetic Services (GPAS) 2019. London: RCoA, 2019. www.rcoa.ac.uk/gpas2019 [Accessed 8th October 2019].
  29. ↵
    1. National Confidential Enquiry into Patient Outcome and Death
    . Highs and lows. London: NCEPOD, 2018. www.ncepod.org.uk/2018pd.html [Accessed 08 October 2019].
  30. ↵
    1. Pournaras DJ
    , Photi ES, Barnett N, et al. Assessing the quality of primary care referrals to surgery of patients with diabetes in the East of England: A multi-centre cross-sectional cohort study. Int J Clin Pract 2017;71:e12971.
    OpenUrl
  31. ↵
    1. Moghissi ES
    , Korytkowski MT, Dinardo MM, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119–31.
    OpenUrlFREE Full Text
  32. ↵
    1. Kushner FG
    , Hand M, Smith SC, et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (Updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (Updating the 2005 guideline and 2007 focused update). Circulation 2009;120:2271–306.
    OpenUrlFREE Full Text
  33. ↵
    1. Tardif J-C
    , L'Allier PL, Fitchett DH. Management of acute coronary syndromes. Can J Diabetes 2018;42:S190–5.
    OpenUrl
  34. ↵
    1. Ryden L
    , Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34:3035–87.
    OpenUrlCrossRefPubMed
  35. ↵
    1. National Institute for Health and Care Excellence
    . Hyperglycaemia in acute coronary syndromes: management. Clinical guideline [CG130]. NICE, 2011. www.nice.org.uk/guidance/cg130 [Accessed 22 July 2019].
  36. ↵
    1. Scottish Intercollegiate Guidelines Network
    . SIGN 148: Acute coronary syndrome: A national clinical guideline. Edinburgh: SIGN, 2016. www.sign.ac.uk/sign-148-acute-coronary-syndrome.html [Accessed 22 July 2019].
  37. ↵
    1. Donihi AC
    , Raval D, Saul M, et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006;12:358–62.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Narwani V
    , Swafe L, Stavraka C, Dhatariya K. How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoids? Clin Med 2014;14:327–8.
    OpenUrlFREE Full Text
  39. ↵
    1. Tatalovic M
    , Lehmann R, Cheetham M, et al. Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review. BMJ Open 2019;9:e028914.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Dashora U
    , Alban Davies H, Bennett S, et al. Findings of a nationwide survey of the diabetes education and training needs of midwives in the UK. Br J Diab 2018;18:147–53.
    OpenUrl
  41. ↵
    1. National Institute for Health and Care Excellence
    . Diabetes in pregnancy: Management of diabetes and its complications from preconception to the postnatal period. NICE guideline [NG3]. NICE, 2018. www.nice.org.uk/guidance/ng3/evidence/full-guideline-3784285 [Accessed 08 October 2019].
  42. ↵
    1. Dashora U
    , Murphy HR, Temple RC, et al. Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes. Diabetic Med 2018;35:1005–10.
    OpenUrl
  43. ↵
    1. Levy N
    , Hall GM. National guidance contributes to the high incidence of inpatient hypoglycaemia. Diabetic Med 2019;36:120–1.
    OpenUrl
  44. ↵
    1. Yamamoto JM
    , Murphy HR. Inpatient hypoglycaemia; should we should we focus on the guidelines, the targets or our tools? Diabetic Med 2019;36:122–3.
    OpenUrl
  45. ↵
    1. Dashora U
    , George S, Sampson M, Walden E. National guidelines have contributed to safer care for inpatients with diabetes. Diabetic Med 2019;36:124–6.
    OpenUrl
  46. ↵
    1. Frankel AH
    , Kazempour-Ardebili S, Bedi R, et al. Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal Association. Diabetic Med 2018;35:1018–26.
    OpenUrl
  47. ↵
    1. Game FL
    , Chipchase SY, Hubbard R, et al. Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant 2006;21:3207–10.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Clark A
    , Kraut E, Yen HH, et al. Evaluation of a diabetic ketoacidosis order set in adults with type 1 and type 2 diabetes at a tertiary academic medical centre: A retrospective chart audit. Can J Diabetes 2019;43:304–8.e3.
    OpenUrl
  49. ↵
    1. Galm BP
    , Bagshaw SM, Senior PA. Acute management of diabetic ketoacidosis in adults at 3 teaching hospitals in Canada: A multicentre, retrospective cohort study. Can J Diabetes 2019;43:309–15.e2.
    OpenUrl
  50. ↵
    1. Francis R
    . Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry. Volume 1: Analysis of evidence and lessons learned (part 1). London: The Stationery Office, 2013. www.gov.uk/government/uploads/system/uploads/attachment_data/file/279115/0898_i.pdf [Accessed 08 October 2019].
  51. ↵
    1. Dashora U
    , Sampson M, Castro E, et al. Rowan Hillson Insulin Safety Award ‘best in class’ insulin prescription chart competition. Br J Diab 2015;15:135–8.
    OpenUrl
  52. ↵
    1. Dashora U
    , Sampson M, Castro E, et al. The best joint pharmacy and diabetes team initiative to improve insulin and prescribing safety in hospital. Br J Diab 2018;18:163–6.
    OpenUrl
  53. ↵
    1. Dashora U
    , Sampson M, Castro E, et al. The Rowan Hillson Inpatient Diabetes Safety Award 2017 for the best digital initiative. Br J Diab 2018;18:110–2.
    OpenUrl
  54. ↵
    1. Dashora U
    , Sampson M, Castro E, et al. The best hypoglycaemia avoidance initiative in the UK. Br J Diab 2017;17:74–7.
    OpenUrl
  55. ↵
    1. Boughton CK
    , Bally L, Martignoni F, et al. Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial. Lancet Diabetes & Endocrinology 2019;7:368–77.
    OpenUrl
  56. ↵
    1. Bally L
    , Thabit H, Hartnell S, et al. Closed-loop insulin delivery for glycemic control in noncritical care. N Eng J Med 2018;379:547–56.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Bain A
    , Hasan SS, Babar ZD. Interventions to improve insulin prescribing practice for people with diabetes in hospital: a systematic review. Diabetic Med 2019;36:948–60.
    OpenUrl
  58. ↵
    1. Evans K
    , Green E, Hudson B. Clinical guideline: Guidelines for managing continuous subcutaneous insulin infusion (CSII, or ‘insulin pump’) therapy in hospitalised patients. ABCD DTN-UK. https://abcd.care/sites/abcd.care/files/CSII_DTN_FINAL%20210218.pdf [Accessed 21st November 2019].
View Abstract
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Safe care for people with diabetes in hospital
Ketan Dhatariya, Omar G Mustafa, Gerry Rayman
Clinical Medicine Jan 2020, 20 (1) 21-27; DOI: 10.7861/clinmed.2019-0255

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Safe care for people with diabetes in hospital
Ketan Dhatariya, Omar G Mustafa, Gerry Rayman
Clinical Medicine Jan 2020, 20 (1) 21-27; DOI: 10.7861/clinmed.2019-0255
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Introduction
    • The patient perspective
    • The National Diabetes Inpatient Audit
    • Hypoglycaemia
    • Diabetes at the front door
    • Perioperative diabetes care
    • Hyperglycaemia and acute coronary syndrome
    • Hyperglycaemia and glucocorticoid use
    • Diabetes in the delivery suite
    • Diabetes on the renal unit
    • Protocol driven management of dysglycaemia
    • Technology and innovation in diabetes
    • Summary and conclusion
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks
  • Google Scholar

More in this TOC Section

  • Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review
  • Optimising the management of osteoporosis
  • Diabetes technologies – what the general physician needs to know
Show more Review

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2020 by the Royal College of Physicians